Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valens Pharmachem is an Indian pharmaceutical company specializing in the research, development, and manufacturing of high-quality Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Established in 2014 and headquartered in Ahmedabad, the company focuses on complex small molecules across diverse therapeutic areas such as cardiology, endocrinology, and neuropsychiatry. Their portfolio includes advanced generic APIs like SGLT2 inhibitors, DPP-4 inhibitors, and novel anticoagulants. Valens Pharmachem operates modern manufacturing facilities that adhere to stringent quality standards, providing custom synthesis and contract manufacturing services to the global pharmaceutical industry. The company is recognized for its expertise in process chemistry and its ability to scale up complex chemical syntheses efficiently.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valens Pharmachem.